UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________
FORM 8-K
______________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 22, 2017
______________
AOXING PHARMACEUTICAL COMPANY, INC.
(Exact name of registrant as specified in its charter)
______________

Florida
0-24185
65-0636168
(State or Other Jurisdiction  of Incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)

1098 Foster City Blvd., Suite 106-810, Foster City, CA 94404
(Address of Principal Executive Office) (Zip Code)

(646) 367 1747
(Registrant's telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.07  Submission of Matters to a Vote of Security Holders

On June 22, 2017, Aoxing Pharmaceutical Company, Inc. (the "Company") held its annual shareholder meeting. The shareholders approved the following proposals:

Proposal 1 - Election of Directors. The shareholders elected Zhenjiang Yue, Jun Min, Guozhu Xu, Yang Li and Yuelin Zhang as directors to hold office until the next annual meeting of shareholders and until their successors are duly elected. A summary of votes cast follows below:

Nominee
 
Votes for
   
Votes Withheld
   
Broker
Non-Votes
 
Zhenjiang Yue
   
45,917,521
     
34,044
     
0
 
Jun Min
   
45,917,242
     
34,323
     
0
 
Guozhu Xu
   
45,905,123
     
46,442
     
0
 
Yang Li
   
45,918,021
     
33,544
     
0
 
Yuelin Zhang
   
45,918,232
     
33,333
     
0
 

Proposal 2 - To ratify the appointment of BDO China Shu Lun Pan Certified Accountants, LLP as independent registered public accounting firm of the Company for the fiscal year ending June 30, 2017. This proposal was approved with 46,278,135 shares voting for and 7,349 shares voting against it (with 13,416 abstaining votes).


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

         
Aoxing Pharmaceutical Company, Inc.
   
  
Date:  June 22, 2017
 
By:  
/s/ Zhenjiang Yue
    Zhenjiang Yue, Chief Executive Officer

 

Aoxing Pharmaceutical Company New (delisted) (AMEX:AXN)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Aoxing Pharmaceutical Company New (delisted) Charts.
Aoxing Pharmaceutical Company New (delisted) (AMEX:AXN)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Aoxing Pharmaceutical Company New (delisted) Charts.